Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide

Imagem de Miniatura
Arquivos
art_SHAH_AlcoholRelated_Liver_Disease_Is_Rarely_Detected_at_Early_2019.PDF (1.59 MB)
Citações na Scopus
86
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
SHAH, Neil D.
VENTURA-COTS, Meritxell
ABRALDES, Juan G.
ALBORAIE, Mohamed
ALFADHLI, Ahmad
ARGEMI, Josepmaria
BADIA-ARANDA, Ester
ARUS-SOLER, Enrique
BARRITT, A. Sidney
BESSONE, Fernando
Citação
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, v.17, n.11, p.2320-+, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND & AIMS: Despite recent advances in treatment of viral hepatitis, liver-related mortality is high, possibly owing to the large burden of advanced alcohol-related liver disease (ALD). We investigated whether patients with ALD are initially seen at later stages of disease development than patients with hepatitis C virus (HCV) infection or other etiologies. METHODS: We performed a cross-sectional study of 3453 consecutive patients with either early or advanced liver disease (1699 patients with early and 1754 with advanced liver disease) seen at 17 tertiary care liver or gastrointestinal units worldwide, from August 2015 through March 2017. We collected anthropometric, etiology, and clinical information, as well as and model for end-stage liver disease scores. We used unconditional logistic regression to estimate the odds ratios for evaluation at late stages of the disease progression. RESULTS: Of the patients analyzed, 81% had 1 etiology of liver disease and 17% had 2 etiologies of liver disease. Of patients seen at early stages for a single etiology, 31% had HCV infection, 21% had hepatitis B virus infection, and 17% had nonalcoholic fatty liver disease, whereas only 3.8% had ALD. In contrast, 29% of patients seen for advanced disease had ALD. Patients with ALD were more likely to be seen at specialized centers, with advanced-stage disease, compared with patients with HCV-associated liver disease (odds ratio, 14.1; 95% CI, 10.5-18.9; P < .001). Of patients with 2 etiologies of liver disease, excess alcohol use was associated with 50% of cases. These patients had significantly more visits to health care providers, with more advanced disease, compared with patients without excess alcohol use. The mean model for end-stage liver disease score for patients with advanced ALD (score, 16) was higher than for patients with advanced liver disease not associated with excess alcohol use (score, 13) (P < .01). CONCLUSIONS: In a cross-sectional analysis of patients with liver disease worldwide, we found that patients with ALD are seen with more advanced-stage disease than patients with HCV-associated liver disease. Of patients with 2 etiologies of liver disease, excess alcohol use was associated with 50% of cases. Early detection and referral programs are needed for patients with ALD worldwide.
Palavras-chave
NAFLD, Mortality, Cirrhosis
URI
https://observatorio.fm.usp.br/handle/OPI/34011
Referências
  1. Addolorato G, 2016, J HEPATOL, V65, P618, DOI 10.1016/j.jhep.2016.04.029
  2. Banini BA, 2017, AM J GASTROENTEROL, V112, P821, DOI [10.1038/ajg.2017.83, 10.1038/ajg.2017.187]
  3. Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950
  4. de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022
  5. GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124
  6. Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
  7. Huang Y, 2014, J HEPATOL, V61, P22, DOI 10.1016/j.jhep.2014.02.031
  8. Kim WR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14126
  9. Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004
  10. Ndugga N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013620
  11. Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
  12. SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x
  13. Shoreibah M, 2016, ANN HEPATOL, V15, P183, DOI 10.5604/16652681.1193707
  14. Stein E, 2016, J HEPATOL, V65, P998, DOI 10.1016/j.jhep.2016.06.018
  15. Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156
  16. Thiele M, 2016, GASTROENTEROLOGY, V150, P123, DOI 10.1053/j.gastro.2015.09.040
  17. Westwood G, 2017, J HEPATOL, V67, P559, DOI 10.1016/j.jhep.2017.04.017
  18. World Health Organization, 2018, GLOB STAT REP ALC HL

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - ODS/03